Clinical Trials Directory

Trials / Unknown

UnknownNCT01181388

Impacts of Superselective Infarct-related Artery (IRA) Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in Acute Myocardial Infarction (AMI) Patients

Impacts of Superselective Infarct-related Artery Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in ST Segment Elevation Myocardial Infarction (STEMI) Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Beijing Anzhen Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Superselective IRA infusion of tirofiban may improve myocardial reperfusion and reduce bleeding complications in AMI patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREadministration of tirofiban by thrombus aspiration catheter in infarct-related arterya bolus of 10ug/kg tirofiban administration via thrombus aspiration catheter followed by 0.1ug/kg/min for 12 hours after PCI
PROCEDUREadministration of tirofiban by guide cathetera bolus of 10ug/kg tirofiban administration via guide catheter followed by 0.1ug/kg/min for 12 hours after PCI

Timeline

Start date
2010-04-01
Primary completion
2012-04-01
Completion
2012-10-01
First posted
2010-08-13
Last updated
2010-08-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01181388. Inclusion in this directory is not an endorsement.